Full-Time

Associate Clinical Oncology Specialist

Posted on 9/27/2024

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$110k - $130kAnnually

Entry, Junior

Baltimore, MD, USA

Preference for candidates living in the Baltimore metro area.

Category
Healthcare Administration & Support
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Sales
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree preferred or Associate’s degree with minimum of 4 years of relevant experience
  • Medical assistant or nursing background is a plus
  • Minimum of 2 years of sales experience or clinical support/caregiver experience, such as OCN or other.
  • Proficient in Microsoft PowerPoint and Excel; Gmail
  • Fluent in understanding data spreadsheets and technologies
  • Demonstrated ability to quickly learn software and reporting systems
Responsibilities
  • Work with assigned COS to grow, maintain & support existing customers
  • Build relationships with key personnel at assigned Oncology accounts to facilitate unit growth.
  • Analyze and monitor patient testing to ensure that patients remain on the protocol prescribed by the Oncologist.
  • Assess the needs of medical professionals and staff members with a focus on customer support, coordination of logistics, and problem solving
  • Become experts on all Natera Oncology products and processes to maximize effectiveness in the field.
  • Educate medical professionals on the tools and resources that Natera provides to facilitate test order management
  • Utilize and maintain internal reports of key performance indicators (KPIs) related to patient retention and fulfilled order volume.
  • Be a key team player within the sales organization who can partner with internal stakeholders, such as sales reps, patient coordinators, territory managers, etc., to achieve the best outcomes for the patient and the provider.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera also offers tests for family planning and prenatal screening, including the Panorama NIPT, which has conducted over 2 million tests. The company generates revenue through testing kits and services, often reimbursed by insurance, and provides genetic counseling for personalized patient support.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's customized genetic tests.

What critics are saying

  • Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE